JC
Insider
Jon Congleton
Chief Executive OfficerJon Congleton (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $9.1M of MLYS (200,000 sh across 6 lots, as filed), executed Nov 11 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$14.8M
shares × price, as filed
Last traded
Jul 13
Filed Jul 15
Median ADV $38.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $15.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 12 months
Most traded names
MLYS
Mineralys Therapeutics, Inc.
MLYS · 0 buys · 11 sells
11 filings
Recent filings
MLYSSALE
Mineralys Therapeutics, Inc.
View filing →
$187K15,319 sh × $12.19
Exec Apr 11 2025
Filed Apr 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $166K
18,333 sh × $9.06
Exec Jan 13 2025
Filed Jan 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $206K
15,271 sh × $13.52
Exec Oct 11 2024
Filed Oct 15 2024 · 5:30 PM ET